Regeneron Pharmaceuticals, Inc.

U.S. Capital Wealth Advisors, LLC REGN

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/7/2026

Shares

1,432

Value ($000)

1,107

Weight

0.0%

2022 Q4 - 2026 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/7/2026	1,107	0.0%	1,432	3/31/2026
2025 Q4	1/23/2026	374	0.0%	484	12/31/2025
2025 Q3	10/9/2025	274	0.0%	487	9/30/2025
2025 Q2	7/14/2025	241	0.0%	459	6/30/2025
2025 Q1	4/29/2025	263	0.0%	414	3/31/2025
2024 Q4	1/24/2025	306	0.0%	429	12/31/2024
2024 Q3	10/22/2024	2,286	0.1%	2,175	9/30/2024
2024 Q2	7/11/2024	2,286	0.1%	2,175	6/30/2024
2024 Q1	5/10/2024	2,029	0.1%	2,108	3/31/2024
2023 Q4	2/6/2024	1,131	0.0%	1,288	12/31/2023
2023 Q3	10/19/2023	858	0.0%	1,043	9/30/2023
2023 Q2	8/4/2023	749	0.0%	1,042	6/30/2023
2023 Q1	5/11/2023	708	0.0%	862	3/31/2023
2022 Q4	2/3/2023	621	0.0%	861	12/31/2022